No Data
No Data
Maipu Medical (301033.SZ) was granted a cumulative increase of 5,200 shares by Director and General Manager Wang Jianhua
Zhitong Finance App News, Maipu Medical (301033.SZ) announced that Wang Jianhua, the company's director and general manager, has already passed halfway through the plan to increase his holdings. Wang Jianhua has increased his holdings by 5,200 shares, accounting for 0.0079% of the company's total share capital. The increase amount is 152,800 yuan (not including transaction fees).
Maipu Medical (301033.SZ) announced first-quarter results, net profit of 149.44,800 yuan, an increase of 91.19% year-on-year
Maipu Medical (301033.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved an operating income of 5...
Maipu Medical (301033.SZ): Achieving revenue of 231 million yuan in 2023, plans to distribute 10 to 4 yuan
Gelonghui, April 18 | Maipu Medical (301033.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 231 million yuan, an increase of 18.24%; net profit attributable to shareholders of listed companies was 408.774 million yuan, up 13.89% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 37.233 million yuan, an increase of 55.54% year on year; basic earnings per share of 0.62 yuan; it plans to distribute a cash dividend of 4.00 yuan (tax included) to all shareholders for every 10 shares.
Medprin Regenerative Medical Technologies Co., Ltd. (SZSE:301033) CEO Yuyu Yuan, the Company's Largest Shareholder Sees 18% Reduction in Holdings Value
Key Insights Medprin Regenerative Medical Technologies' significant insider ownership suggests inherent interests in company's expansion 54% of the business is held by the top 6 shareholders 14%
Maipu Medicine (301033.SZ): Focus on the field of neurosurgery
Gelonghui, March 21丨Maipu Medical (301033.SZ) said on the investor interactive platform that currently the company is focusing on the field of neurosurgery. The main products are implanted medical device products such as artificial hard brain (spine) membrane patches, craniomaxillofacial repair and fixation systems, absorbable regenerated cellulose, and dural medical gel.
Maipu Medical (301033.SZ): Initial repurchase of 581,000 shares involving 1,837,600 yuan
Gelonghui, March 5, 丨 Maipu Medical (301033.SZ) announced that on March 5, 2024, for the first time, the company repurchased 581,000 shares of the company through a special stock repurchase securities account. The number of shares repurchased accounted for 0.0879% of the company's total share capital. The highest transaction price was 32.68 yuan/share, the minimum transaction price was 31.39 yuan/share, and the total repurchase amount was 1,837,600 yuan (not including transaction fees).
No Data